Market Forecast by Countries (Saudi Arabia, UAE, Qatar, Kuwait, Oman, Bahrain and Turkey), By Study Design (Interventional, Expanded Access, Observational), By Indication (Cardiovascular, Oncology, Others) And Competitive Landscape
Product Code: ETC080310 | Publication Date: Aug 2021 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 200 | No. of Figures: 90 | No. of Tables: 30 |
Middle East Virtual Clinical Trials Market is expected to register growth in the coming years. In Middle East, the modernization of clinical trials to improve productivity and collect information from many sources is a component anticipated to propel the growth of the clinical trial market in the next few years. The growing rate of neurological diseases like tumours, depression, epilepsy, Parkinson's, and Alzheimer's combined with the increasing geriatric population are components anticipated to boost the growth of the virtual clinical trial market over the period. Growing clinical trials to find reliable and effective solutions to prevent the spread of neurological disorders and age-related diseases are components that will boost the growth of the virtual clinical trials market. The Market growth can be hampered due to emerging shortage of well-trained labour. The virtual trial model does not work well for trials that require a lot of office visits or complex procedures. Trials that require radiographic procedures, surgical procedures such as biopsies, or complex investigational product administration may not be ideal because these procedures cannot be done at a patient’s home and require a specialist to complete. It is also operationally challenging to have all procedures done virtually. Data security is another potential challenge. Large amounts of patients’ personal data are transmitted via the Internet. They need to ensure patients are aware of the risk of data breaches in the informed consent form. COVID-19 is making virtual and decentralized approaches to clinical trials necessary.
According the 6Wresearch, the Middle East Virtual Clinical Trials Market is likely to witness significant growth during 2021-2027.Dubai has first virtual hospital in the Middle East Region last year. UAE’s Mubadala ventures joins Virtual trial Platform Science 37. As the Science 37 company democratize clinical research by bringing trials directly to the patients is not only the right thing to do, but it also has had a clear, measurable impact on sponsors’ ability to access a more diverse patient population, accelerate research, and bring new medicines to the market faster. UAE’s Health at Hand start-up offers customers video consultations with regional doctors, and claims to be the first healthcare provider to be licenced by the Dubai Health Authority to provide telehealth services.
The Middle East Virtual Clinical trial market is segmented on the basis of Study type, By indication, and by Regions. Based on study type the market is bifurcated into Interventional, observational and expanded access and others. Based on Indication the market bifurcated into Oncology, cardiovascular, Immunology, Gastrointestinal, Respiratory, Endocrinology, Ophthalmology and other indications. Based on region the market is divided into North America, Latin America, Middle east, Africa, Europe and Asia Pacific. The existence of the leading players and benefits environment for carrying out clinical trials is another element anticipated to push the growth of the clinical trial in the regions. The Key players profiled Virtual clinical trial market are Chiltern, Omnicare, PPD, kendle, Quintles, ICON PLC, Charles River, Parexel. An increasing number of biotechnology firms are looking at the Latin America region for the Covid19 trials to take advantage of the large patient pool and fast track procedures. An increasing number of biotechnology firms are looking at the Europe region for the Covid19 trials to take advantage of the large patient pool and fast track procedures.
The Middle East Virtual Clinical trial market report thoroughly covers the market by study, indications and key countries including Dubai, Saudi Arabia, Jordan, Oman, Yemen. The Middle East Virtual Clinical Trial market outlook report provides an unbiased and detailed analysis of the on-going Middle East market trends, high growth areas and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
Markets Covered
The Market Report covers the following segment:
Other Key Reports Available:
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Middle East Virtual Clinical Trials Market Overview |
3.1 Middle East Regional Macro Economic Indicators |
3.2 Middle East Virtual Clinical Trials Market Revenues & Volume, 2020 & 2027F |
3.3 Middle East Virtual Clinical Trials Market - Industry Life Cycle |
3.4 Middle East Virtual Clinical Trials Market - Porter's Five Forces |
3.5 Middle East Virtual Clinical Trials Market Revenues & Volume Share, By Countries, 2020 & 2027F |
3.6 Middle East Virtual Clinical Trials Market Revenues & Volume Share, By Study Design, 2020 & 2027F |
3.7 Middle East Virtual Clinical Trials Market Revenues & Volume Share, By Indication, 2020 & 2027F |
4 Middle East Virtual Clinical Trials Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Middle East Virtual Clinical Trials Market Trends |
6 Saudi Arabia Virtual Clinical Trials Market, 2017 - 2027 |
6.1.1 Saudi Arabia Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
6.1.2 Saudi Arabia Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
7 UAE Virtual Clinical Trials Market, 2017 - 2027 |
7.1 UAE Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
7.2 UAE Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
8 Qatar Virtual Clinical Trials Market, 2017 - 2027 |
8.1 Qatar Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
8.2 Qatar Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
9 Kuwait Virtual Clinical Trials Market, 2017 - 2027 |
9.1 Kuwait Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
9.2 Kuwait Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
10 Oman Virtual Clinical Trials Market, 2017 - 2027 |
10.1 Oman Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
10.2 Oman Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
11 Bahrain Virtual Clinical Trials Market, 2017 - 2027 |
11.1 Bahrain Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
11.2 Bahrain Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
12 Turkey Virtual Clinical Trials Market, 2017 - 2027 |
12.1 Turkey Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
12.2 Turkey Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
13 Rest of Middle East Virtual Clinical Trials Market, 2017 - 2027 |
13.1 Rest of Middle East Virtual Clinical Trials Market, Revenues & Volume, By Study Design, 2017 - 2027 |
13.2 Rest of Middle East Virtual Clinical Trials Market, Revenues & Volume, By Indication, 2017 - 2027 |
14 Middle East Virtual Clinical Trials Market Key Performance Indicators |
15 Middle East Virtual Clinical Trials Market - Opportunity Assessment |
15.1 Middle East Virtual Clinical Trials Market Opportunity Assessment, By Countries, 2020 & 2027F |
15.2 Middle East Virtual Clinical Trials Market Opportunity Assessment, By Study Design, 2020 & 2027F |
15.3 Middle East Virtual Clinical Trials Market Opportunity Assessment, By Indication, 2020 & 2027F |
16 Middle East Virtual Clinical Trials Market - Competitive Landscape |
16.1 Middle East Virtual Clinical Trials Market Revenue Share, By Companies, 2020 |
16.2 Middle East Virtual Clinical Trials Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Company Profiles |
18 Recommendations |
19 Disclaimer |